Research Paper Volume 13, Issue 15 pp 19415—19441

Development and validation of an intra-tumor heterogeneity-related signature to predict prognosis of bladder cancer: a study based on single-cell RNA-seq

The candidate compounds targeting HRS. (A) The volcano plot displayed the DEGs between low-HRS and high-HRS cases. (B–I) Seven compounds, including cephaeline (C), LY-294002 (D), lycorine (E), naltrexone (F), nefopam (G), tanespimycin (H), and wortmannin (I), were identified.

Figure 9. The candidate compounds targeting HRS. (A) The volcano plot displayed the DEGs between low-HRS and high-HRS cases. (BI) Seven compounds, including cephaeline (C), LY-294002 (D), lycorine (E), naltrexone (F), nefopam (G), tanespimycin (H), and wortmannin (I), were identified.